Printed from Voxsanity (voxsanity.com.au) — NCT02174549 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Liver Cancer
Phase 2 Liver Cancer Trial, Recruiting
NCT02174549
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a well-differentiated neuroendocrine tumour (NET) that has spread to the liver, where the liver is the main site of disease, regardless of where the original tumour started or whether the tumour is producing hormones.
- People whose liver tumours, while any size or number, make up no more than 50% of the total liver volume.
- People who have previously received treatments for their NET, including approved medications, surgery, tumour ablation, or procedures that target blood supply to the liver.
- People aged 20 or older who are reasonably active and functioning in daily life (confirm with trial site), and who do not have known major heart, lung, or kidney problems.
- People whose treating specialist (interventional radiologist) considers them suitable for a liver artery procedure called TAE or TACE, and who do not have a blockage in the main vein supplying the liver.
- People whose blood test results meet specific thresholds for blood cell counts, kidney function, liver function, and blood clotting (confirm exact values with trial site).
- Women who could become pregnant must use highly effective contraception during the trial and for 6 months after the last dose of the study drug; men whose partners could become pregnant must use highly effective contraception, including a barrier method, during the trial and for 3 months after the last dose.
Who may not be able to join:
- People whose liver tumours make up more than 50% of the total liver volume.
- People with a blockage of the main portal vein supplying the liver.
- People whose blood test results fall outside the required ranges for blood counts, kidney function, liver function, or clotting (confirm with trial site).
- People under 20 years of age.
- People with known major heart, lung, or kidney problems.
- People who are not considered suitable candidates for a TAE or TACE liver procedure by their treating specialist.
- Women who could become pregnant and are unwilling or unable to use highly effective contraception during the trial and for 6 months after the last dose of the study drug.
- Men whose partners could become pregnant and are unwilling or unable to use highly effective contraception, including a barrier method, during the trial and for 3 months after the last dose.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Recruiting
Phase
Phase 2
Sponsor
Teclison Ltd.
Registry
ClinicalTrials.gov
Start date
1 September 2014
Est. completion
31 March 2028
Where this trial is recruiting
🇺🇸 United States
Primary endpoints
Overall Response rate (ORR) by RECIST
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.